• MK-8745: Aurora A Inhibitor Workflows

  2026-08-31

  MK-8745 converts selective Aurora A inhibition into practical assays for mitotic arrest, tetraploidy, and apoptosis. This guide connects retinoblastoma target biology with reproducible cell-based, lymphoma, and xenograft-oriented workflows while emphasizing solvent handling and phenotype validation.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-31

  Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use with rabbit primary antibodies and should not be treated as a diagnostic reagent or assumed to be suitable for live-cell applications because the supplied formulation contains sodium azide.

• Biomimetic Nanoplatform for Metastatic TNBC

  2026-08-30

  The ACS Nano study developed a biomimetic nanoplatform that combines photothermal tumor ablation with tumor vaccination and immune-checkpoint modulation. Its staged, tumor-responsive design improved primary tumor targeting and generated immune effects intended to limit recurrence and metastasis in preclinical triple-negative breast cancer models.

• BCL-XL Inhibition: From Apoptotic Priming to Translation

  2026-08-29

  A mechanistic and strategic guide to using the BCL-XL inhibitor A-1155463 in glioblastoma and broader cancer research, with emphasis on apoptotic priming, model selection, platelet pharmacodynamics, and translational decision-making.

• MEK Inhibition Rewires T-Cell Responses After Radiotherapy

  2026-08-28

  The 2025 Frontiers in Immunology study identifies a cGAS–STING–CXCL10 pathway through which MEK inhibition improves T-cell recruitment and function after radiotherapy in KRAS-mutant lung cancer models. Its findings connect impaired DNA repair with innate immune activation and suggest that combining MEK inhibition with lower-dose radiotherapy merits further preclinical evaluation.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-28

  The reference study shows that puerarin enhances the osteogenic differentiation of rat dental follicle cells while increasing nitric oxide, cGMP, and osteogenic marker expression. Pharmacological inhibition with L-NMMA reversed these effects, supporting a functional role for nitric oxide pathway activation in periodontal regeneration research.

• FGF4-FGFR1 Protects Podocytes in Diabetic Kidney Disease

  2026-08-27

  This Nature Communications study identifies podocyte-derived FGF4 as an endogenous protective factor that declines in diabetic kidney disease and links its loss to podocyte depletion and impaired glomerular function. Genetic deletion and recombinant-protein rescue experiments support an FGFR1–AMPK–FOXO1 mechanism that limits oxidative stress and apoptosis, providing a mechanistically focused framework for studying podocyte preservation in diabetes.

• FH1 for iPS-Derived Hepatocyte Maturation

  2026-08-27

  FH1 small molecule helps turn iPS-derived hepatocyte-like cells into more functional research models by increasing albumin secretion, supporting CYP3A4 expression, and reducing AFP. This guide combines a controlled FH1 workflow with assay selection, stock-handling advice, troubleshooting, and a cautious bridge to light-regulated liver gene therapy research.

• EZ Cap™ EPO mRNA: Assay Design for Local Translation

  2026-08-26

  EZ Cap™ EPO mRNA is a Cap 1, pseudouridine-modified platform for studying localized erythropoietin expression. This article translates recent spinal cord injury findings into practical assay design, controls, and evidence-based interpretation for mammalian research.

• From Nutrient Stress to S-Phase: Translational EdU

  2026-08-26

  Nutrient availability, immune pressure, and tumor-cell proliferation are tightly connected—but translational decisions require measurements that separate mechanism from assumption. This article examines how EdU-based S-phase analysis and the EdU Flow Cytometry Assay Kits (Cy5) can strengthen metabolic oncology studies, including research inspired by findings on serine/glycine restriction and PD-L1 lactylation in colorectal cancer.

• Rotavirus Infection Suppresses Nrf2 Redox Defense

  2026-08-25

  The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive induction followed by pronounced loss of Nrf2, nuclear depletion, and suppression of antioxidant target genes. Its mechanistic experiments suggest that late Nrf2 depletion is not explained solely by canonical Keap1 turnover but involves proteasome-associated, K48-linked ubiquitination, providing a useful framework for studying virus-driven stress adaptation.

• WZ4003 Lowers Tau p-Ser356 in Brain Models

  2026-08-25

  Taylor et al. characterize tau phosphorylation at Ser356 as an Alzheimer’s disease-associated pathological feature and test pharmacological NUAK1/2 inhibition in mouse and human brain tissue models. Their results show that WZ4003 lowers p-tau Ser356 in live human brain slices, while mouse organotypic cultures display a broader, culture-phase-dependent reduction in tau and synaptic proteins.

• Drosophila Keap1 Nuclear Condensates Under Oxidative Stress

  2026-08-24

  The reference study identifies oxidative-stress-induced nuclear condensate assembly as a previously unrecognized property of Drosophila Keap1. Through live-cell imaging, FRAP, domain analysis, and in vitro reconstitution, it links condensate formation to the dKeap1 N- and C-terminal regions, intrinsically disordered regions, and suppression by the Kelch domain.

• Amphotericin B: Applied Assay Workflows

  2026-08-24

  Amphotericin B converts fungal membrane sterol biology into measurable loss of viability, while also enabling controlled studies of innate immune activation. This practical guide covers concentration planning, orthogonal readouts, cross-domain assay design, and troubleshooting for reproducible fungal infection research.

• From Caspase-3 Inhibition to Pyroptosis Insight

  2026-08-23

  Z-DEVD-FMK offers translational researchers a mechanistic tool for separating caspase-driven apoptosis from gasdermin-associated lytic death, while its calpain activity broadens interpretation in neuronal injury models.

7930 records 1/529 page Next 12345 下5页 Last page